Vertex Pharma (VRTX) Granted European CHMP Positive Opinion for KALYDECO for Children/Adolescents with CF and R117H Mutation in CFTR Gene
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
- S&P 500 falls as AI worries hit software makers
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Vertex (VRTX) PT Raised to $305 at Citi
May 1, 2020 5:17 AM EDTCiti analyst Mohit Bansal raised the price target on Vertex (NASDAQ: VRTX) to $305.00 (from $265.00) while maintaining a Buy rating.... More
Vertex (VRTX) PT Raised to $305 at Citi
April 30, 2020 4:12 PM EDTCiti analyst Mohit Bansal raised the price target on Vertex (NASDAQ: VRTX) to $305.00 (from $265.00) while maintaining a Buy rating.
... MoreVertex (VRTX) PT Raised to $277 at Morgan Stanley
April 30, 2020 8:11 AM EDTMorgan Stanley raised its price target on Vertex (NASDAQ: VRTX) to $277.00 (from $258.00) while maintaining a Overweight rating.... More
Vertex (VRTX) PT Raised to $281 at Cantor Fitzgerald
April 30, 2020 6:34 AM EDTCantor Fitzgerald analyst Alethia Young raised the price target on Vertex (NASDAQ: VRTX) to $281.00 (from $275.00) while maintaining a Overweight rating.... More
Vertex (VRTX) PT Raised to $285 at Stifel
April 30, 2020 4:38 AM EDTStifel analyst Paul Matteis raised the price target on Vertex (NASDAQ: VRTX) to $285.00 (from $275.00) while maintaining a Buy rating.... More
Vertex (VRTX) PT Raised to $285 at JMP Securities
April 30, 2020 4:38 AM EDTJMP Securities analyst Joseph Osha raised the price target on Vertex (NASDAQ: VRTX) to $285.00 (from $255.00) while maintaining a Market Outperform rating.... More
Vertex Pharma (VRTX) Tops Q1 EPS by 72c, Revenues Beat; Raises FY20 Revenues Guidance
April 29, 2020 4:04 PM EDTVertex Pharma (NASDAQ: VRTX) reported Q1 EPS of $2.56, $0.72 better than the analyst estimate of $1.84. Revenue for the quarter came in at $1.52 billion versus the consensus estimate of $1.29 billion.
"The COVID-19 pandemic has presented unprecedented challenges to societies, communities and businesses around the world, and while these global challenges will... More
